Editorial. Focuses on the dosage of the prodrug mercaptopurine, which is used to maintain remission in childhood acute lymphoblastic leukemia. Assumption in dosing according to body surface; Catalyst of mercaptopurine's intracellular activation; Functional significance of thiopurine methyltransferase.